Richard Hague, Chairman of the Board, is a highly accomplished life sciences executive and board member with extensive experience in the development and commercialization of innovative cell-based therapies, drug-device combinations and medical devices. Richard’s broad experience includes raising capital in the public and private markets, IND and BLA submissions and approvals, execution of late phase RCTs, multiple new product launches and licensing and M&A transactions.
